What do you want to do today?
video_library
Watch On Demand
auto_awesome_motion
Discover Series
person_search
Search KOLs
campaign
Meet our Ambassadors
group_work
Meet Societies
handshake
Meet Partners
video_library
OnDemand
auto_awesome_motion
Series
person_search
Faculty
campaign
Ambassa-
dors
group_work
Societies
handshake
Partners

Only logged in users can watch the content

Chat keyboard_arrow_down
Description keyboard_arrow_down
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them. In this event, AIS Channel specially invites top thoracic surgery experts from China, the United Kingdom and the United States to share academic insights on anatomical partial lobectomy. This event features medical presentations, operation videos, and interactive discussions to enhance surgical skills and improve global standards in this field.

  1. Hospital/ Department Introduction

  1. Welcome and Introduction - Dr. Shugeng Gao (China)

  1. Anatomical Partial Lobectomy for GGN: Practice and Propagate in China - Dr. Jun Zhao (China) 

  1. Pulmonary Parenchyma Cutting of the Anatomical Partial Lobectomy - Dr. Kai Su (China)

  1. Clinical Decision-making and Reflection on Sublobar Resection Techniques - Dr. Ying Ji (China)

  2. Panel Discussion and Closing Remarks - All faculty moderated by Dr. Shugeng Gao (China)
Faculty keyboard_arrow_down
Dr. Shugeng Gao MD, PhD, Chief of Thoracic Surgery and Vice President, Cancer Hospital, Chinese Academy of Medical Sciences; Tenured Professor, Peking Union Medical College, China Cardiothoracic Surgery
Dr. Ying Ji MD, Chief of Thoracic Surgery and Vice President, Cancer Hospital, Chinese Academy of Medical Sciences; Tenured Professor, Peking Union Medical College, China Cardiothoracic Surgery
Dr. Marco Scarci MD, FRCS(Eng), FCCP, FACS, FEBTS, Consultant Thoracic Surgeon, NHS healthcare Trust, London, United Kingdom Cardiothoracic Surgery
Dr. Kai Su MD, Associate Chief Physician, Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, China Cardiothoracic Surgery
Dr. Scott J. Swanson MD, Professor of Surgery, Harvard Medical School, Director of Minimally Invasive Thoracic Surgery, Brigham and Women’s Hospital, Associate Chief of Surgery, Dana Farber Cancer Institute Cardiothoracic Surgery
Dr. Fan Zhang MD, Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, China Cardiothoracic Surgery
Dr. Jun Zhao MD, Chief Physician, Department of thoracic surgery, Cancer Hospital, Chinese Academy of Medical Sciences, China Radiology
Hospital information keyboard_arrow_down

General Introduction of Department of Thoracic Surgery, Cancer Hospital

Cancer hospital
Cancer Hospital, Chinese Academy of Medical Sciences is the first oncology hospital held by China. The hospital was founded in 1958. In 2009, the Institute became the supporting unit of the National Cancer Center, and the Cancer Institute was incorporated into the National Cancer Center.


Department of Thoracic Surgery
Medical personnel   1 Academician of the Chinese Academy of Science   3 Fellow of Royal College of Surgeons   7 Doctoral supervisor； 15 Professor； 63 Doctors；124 Nurses A total of 7 wards and 245 beds

National Cancer Center of China is as NCI to the United States. Cancer Hospital, Chinese Academy of Medical Sciences is the first cancer hospital in China as well as the Affiliated Cancer Hospital of the 1st Medical University in China (Peking Union Medical University).
We rank 1st in Oncology and Thoracic Surgery on Board of “China best hospital” in 12 consecutive years until 2022 and rank 1st on Board of “Science and technology” in 8 consecutive years until 2022.

The chairman/president unit of all national academic organizations in the thoracic surgery industry, with more than 30 members in our department serving as the Chairman/Deputy Chairman/Standing Committee/Group Leader.
The associations consists of Asian Society of Thoracic Surgeons, Chinese Society for Thoracic and Cardiovascular Surgery and Chinese Association of Thoracic Surgeons.

A total of 9064 patients receiving surgery in our department and a total of 97806 patients visiting our outpatient department in 2021.

Our department has developed and applied a great number of new technologies, including the combination of 3D reconstruction and CT-guided localization guides the resection of multiple and difficult pulmonary nodules, robot-assisted pulmonary resection and resection of chest wall tumor with 3D printing reconstruction.

Presenting an original surgical concept for lung cancer
- Anatomic partial lobectomy: a new surgical concept for the treatment of early lung cancer based on segmental and subsegmental dissection


Anatomic partial lobectomy
- All anatomical sublobectomy procedures are included - Strong inclusiveness, except for typical peripheral pulmonary nodules, the proportion of lung surgery is increasing year by year - APL is the mainstream operation of our hospital, which is easy to popularize.


Research Publication
In 2021, Our department has published 122 research articles, the total IF is 624.651.


Construction of academic promotion and exchange platform
We have constructed the academic promotion and exchange platform in China, aiming to perform the academic promotion for thoracic surgeons and facilitate the improvement of surgical technology.

Related Content keyboard_arrow_down